Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_006044.4(HDAC6):c.404T>G(p.Phe135Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
HDAC6 (HGNC:14064): (histone deacetylase 6) Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It contains an internal duplication of two catalytic domains which appear to function independently of each other. This protein possesses histone deacetylase activity and represses transcription. [provided by RefSeq, Jul 2008]
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), HDAC6. . Gene score misZ 3.2915 (greater than the threshold 3.09). GenCC has associacion of gene with X-linked dominant chondrodysplasia, Chassaing-Lacombe type.
BP4
Computational evidence support a benign effect (MetaRNN=0.23806575).
Uncertain significance, criteria provided, single submitter
clinical testing
Ambry Genetics
Dec 07, 2024
The c.404T>G (p.F135C) alteration is located in exon 6 (coding exon 5) of the HDAC6 gene. This alteration results from a T to G substitution at nucleotide position 404, causing the phenylalanine (F) at amino acid position 135 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of ubiquitination at K138 (P = 0.1181);Gain of ubiquitination at K138 (P = 0.1181);Gain of ubiquitination at K138 (P = 0.1181);Gain of ubiquitination at K138 (P = 0.1181);Gain of ubiquitination at K138 (P = 0.1181);Gain of ubiquitination at K138 (P = 0.1181);Gain of ubiquitination at K138 (P = 0.1181);Gain of ubiquitination at K138 (P = 0.1181);.;Gain of ubiquitination at K138 (P = 0.1181);Gain of ubiquitination at K138 (P = 0.1181);Gain of ubiquitination at K138 (P = 0.1181);.;.;Gain of ubiquitination at K138 (P = 0.1181);Gain of ubiquitination at K138 (P = 0.1181);